Vise Technologies’s Xeris Biopharma Holdings XERS Stock Holding History

Vise Technologies’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$107K	Buy	+11,154	New	+$94.2K	﹤0.01%	2044

Other funds holding XERS

Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Vise Technologies's XERS Position: Q3 2026 in Review

Vise Technologies opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 11,154 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #2044 among its holdings.

52 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

Vise Technologies held 11,154 shares of Xeris Biopharma Holdings worth $107K as of Q3 2026.
Xeris Biopharma Holdings was a new Vise Technologies position in Q3 2026.
Xeris Biopharma Holdings made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #2044 holding.
52 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.